Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients.

PancRISK score enables easy interpretation of the biomarker panel data and is currently being tested to confirm that it can be used for stratification of patients at risk of developing pancreatic cancer completely non-invasively, using urine samples.